Anxiety, depression, traumatic stress and COVID-19-related anxiety in the UK general population during the COVID-19 pandemic by Shevlin, M. et al.
This is a repository copy of Anxiety, depression, traumatic stress and COVID-19-related 
anxiety in the UK general population during the COVID-19 pandemic.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/167364/
Version: Published Version
Article:
Shevlin, M., McBride, O., Murphy, J. et al. (11 more authors) (2020) Anxiety, depression, 
traumatic stress and COVID-19-related anxiety in the UK general population during the 
COVID-19 pandemic. BJPsych Open, 6 (6). e125. 
https://doi.org/10.1192/bjo.2020.109
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Anxiety, depression, traumatic stress and
COVID-19-related anxiety in the UK general
population during the COVID-19 pandemic
Mark Shevlin, Orla McBride, Jamie Murphy, Jilly Gibson Miller, Todd K. Hartman, Liat Levita, Liam Mason,
Anton P. Martinez, RyanMcKay, Thomas V. A. Stocks, Kate M. Bennett, Philip Hyland, Thanos Karatzias and
Richard P. Bentall
Background
The COVID-19 pandemic has created an unprecedented global
crisis, necessitating drastic changes to living conditions, social
life, personal freedom and economic activity. No study has yet
examined the presence of psychiatric symptoms in the UK
population under similar conditions.
Aims
We investigated the prevalence of COVID-19-related anxiety,
generalised anxiety, depression and trauma symptoms in the UK
population during an early phase of the pandemic, and estimated
associations with variables likely to influence these symptoms.
Method
Between 23 and 28 March 2020, a quota sample of 2025 UK
adults aged 18 years and older, stratified by age, gender and
household income, was recruited by online survey company
Qualtrics. Participants completed standardised measures of
depression, generalised anxiety and trauma symptoms relating
to the pandemic. Bivariate and multivariate associations were
calculated for demographic and health-related variables.
Results
Higher levels of anxiety, depression and trauma symptoms were
reported compared with previous population studies, but not
dramatically so. Anxiety or depression and trauma symptoms
were predicted by young age, presence of children in the home,
and high estimates of personal risk. Anxiety and depressionwere
also predicted by low income, loss of income and pre-existing
health conditions in self and others. Specific anxiety about
COVID-19 was greater in older participants.
Conclusions
This study showed a modest increase in the prevalence of
mental health problems in the early stages of the pandemic, and
these problems were predicted by several specific COVID-
related variables. Further similar surveys, particularly of those
with children at home, are required as the pandemic progresses.
Keywords
COVID-19 pandemic; anxiety; depression; traumatic stress; UK
general population survey.
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Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
was first detected in Wuhan, China, on 31 December 2019. The
disease it causes has been named COVID-19. The first UK corona-
virus case was confirmed on 31 January 2020, and on 11March 2020
the World Health Organization declared the global spread of
COVID-19 to be a pandemic. Since then there have been rapidly
increasing cases and deaths associated with the virus globally and
in the UK. On the evening of 23 March 2020, the UK Prime
Minister announced extensive restrictions on freedom of move-
ment, the closure of non-essential businesses and the requirement
to stay at home except for limited purposes. The mental health con-
sequences for the population of an existential threat on the scale of
the current pandemic, and of the associated restrictions on move-
ment and social gatherings, are not well understood. There has
been research on the psychological effects of other infectious
respiratory diseases (IRDs) such as SARS, the H1N1 flu pandemic
and MERS. However, with a few exceptions, which are mostly
from the far east and have focused largely on anxiety and its influ-
ence on risk perception and health behaviours rather than mental
health more broadly,1,2 these studies have predominantly consid-
ered healthcare workers3,4 and patients.5 This absence of knowledge
is troubling because there is plausible evidence from modelling that
emotional and behavioural responses to a pandemic may affect its
course,6 and because the burden of population mental ill-health
may have implications for resources during the pandemic and
national recovery afterwards. In 2003, the Canadian National
Advisory Committee on SARS and Public Health,7 proposed that
a ‘systemic perspective’, which focused not only on medical staff
and patients but also on the general population, should be priori-
tised by all those engaged in IRD psychosocial research. A similar
approach was advocated in a recent UK expert panel convened by
the Academy of Medical Sciences and the mental health research
charity MQ.8
Here, we report initial findings from the first wave of a longitu-
dinal, multi-wave survey of the social and psychological effects of
COVID-19 on the UK population, conducted by researchers in
seven UK and Irish universities (the COVID-19 Psychological
Research Consortium).9 Of note, in a mirror study with similar
methodology, we recently reported the social and psychological
effects of COVID-19 on the population of the Republic of
Ireland.10 The primary aim of this study was to assess the levels of
anxiety, depression and traumatic stress, based on validated self-
report measures, in a large, representative community sample
during an early stage of the pandemic, between 23 and 28 March
2020. Based on the scant previous studies11 and given the dramatic
restrictions imposed because of COVID-19, we expected higher
levels of common psychological and stress symptoms compared
with previous population estimates. Our secondary aim was to iden-
tify groups that are psychologically vulnerable during the pandemic,
by assessing the relationship between levels of anxiety, depression
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and traumatic stress and (a) age; (b) household income; (c) eco-
nomic threat due to COVID-19; (d) health-related risk factors
(being male, self or close friend or relative having a pre-existing
serious health condition); (e) COVID-19 infection status; (f)
anxiety specifically related to COVID-19; (g) perceived risk of
COVID-19 infection; (h) living in an urban area; (i) living as a
lone adult and (j) living with children in the home.
Method
Recruitment and participants
Data collection started on 23March 2020, 52 days after the first con-
firmed COVID-19 case in the UK and on the same day that the UK
Prime Minister announced at 8.30 pm the ‘lockdown’ that required
all people in the UK to stay at home except for very limited pur-
poses, and was completed on 28 March 2020. The fieldwork was
conducted by the survey company Qualtrics. The UK adult popula-
tion aged 18 years and older was the target population, and quota
sampling methods were used to ensure that the sample was repre-
sentative of this population in terms of age and gender, based on
2016 population estimates from Eurostat, and household income
based on the 2017 Office for National Statistics household income
bands. Qualtrics provides an online platform to securely house
data and leverages partners to connect with potential participants
who could have been alerted to the study in one of two ways: (a)
they opted to enter studies they were eligible for themselves by
signing up to a panel platform; or (b) they received automatic noti-
fication through a partner router which alerted them to studies for
which they were eligible (via email, SMS or in-app notifications).
Importantly, to avoid self-selection bias, survey invitations to eli-
gible participants only provided general information and did not
include specific details about the contents of the survey.
Participants were required to be an adult (aged 18 years or older),
able to read and write in English, and a resident of the UK. No
other exclusion criteria were applied. Panel members were not
obliged to take part in the study.
For purposes of quota sampling for age, gender and household
income, Qualtrics proceeded as follows during the 6 days of fieldwork:
(a) respondents in ‘hard to reach’ quota groups (e.g. young adults in
the highest income bands) were prioritised and targeted first; (b)
next, the focus shifted to allow the quotas to ‘fill up’ naturally,
without specific targeting; and (c) finally, a switch back to targeting
respondents to fill incomplete quotas ensued. Participants followed
a link to a secure website and completed all surveys online. The
invite link was active for a participant until a quota they would have
qualified for was reached but after the quota was filled; previously eli-
gible respondents were prevented from taking part in this study.
Participants were informed about the purpose of the study, that
their data would be treated in confidence, that geolocation would be
used to determine the area in which they lived, and of the right to ter-
minate the study at any time without giving a reason. All participants
provided informed consent prior to completing the survey and were
directed to contact the National Health Service 111 COVID-19 help-
line at the end of the survey if they experienced any distress or had
additional concerns about COVID-19. Ethical approval for the
study was granted by the ethical review board of Sheffield
University (the reference number for ethical approval is 033759).
Qualtrics employed checks to identify and remove potential
duplicate respondents or any participants who completed the
survey in less than the minimum completion time (half the
median time of the ‘soft-launch’ with 50 participants) to ensure
responses were trustworthy. The pre-recruitment quotas were
achieved with a high level of accuracy; the quotas were obtained
to within 1 % for gender, 0.1–0.6 % for age bands and 0.25–1 %
for household income bands. The 2014 Adult Psychiatric
Morbidity Survey in England estimated the rate of post-traumatic
stress disorder (PTSD) to be 4.4 %;12 this was lower than the rates
for anxiety and depression. To detect a disorder with a prevalence
of 4 %, with precision of 1 % and a 95 % confidence level, a
sample size of 1476 was required. However, estimating the preva-
lence of disorders with a low prevalence (<5 %) may result in a
small number of ‘cases’ being identified. For instance, a sample
size of 1476 and prevalence of 4 % will identify approximately 60
cases and, if follow-up analyses are based only on these cases,
tests may be underpowered. To detect a correlation of 0.30, with
alpha = 0.05 and power of 0.80, 84 cases are required (or an
overall sample size of 2100). As a compromise between ensuring
adequate sampling to reliably estimate prevalence and adequate
power for subgroup analysis, a target sample size of 2000 partici-
pants was set.
Given the dual processes used by Qualtrics and partners to
recruit respondents to quotas, it was not possible to determine the
number of survey invitations that were distributed to panel
members, or indeed the number of panellists who were alerted to
the survey and who did or did not complete the survey (i.e. the
response rate). Qualtrics did provide some metrics for the study,
as follows: 159 respondents did not provide full informed consent
and were screened out; 35 respondents who completed the survey
from outside the UK or were aged under 18 years were also screened
out; and, to ensure responses were trustworthy, 77 participants who
completed the survey in less than the minimum completion time
were removed, as were 64 potential duplicate respondents. This
resulted in a sample of 2025 participants who completed the
survey over 6 days of fieldwork.
Subsequent checks ensured that the participants were also
representative of the population in terms of voting history,
number of people in household and other important demographic
characteristics.9
Participants were recruited from the four countries of the UK,
proportional to their relative population sizes: England (86.9 %),
Wales (3.1 %), Scotland (7.8 %), Northern Ireland (2.3 %). The
mean age of the sample was 45.44 years (median = 45.00, s.d. =
15.90, range 18–83), and 51.7 % (n = 1047) were female, 48.0 %
were male (n = 972) and 0.3 % (n = 6) checked the transgender/
prefer not to say/other option. Most reported that they were born
in the UK (90.6 %, n = 1834) and grew up (spent most of their life
up to 16 years of age) in the UK (92.4 %, n = 1872). Participants
reported their ethnicity as follows: White British/Irish (n = 1732,
85.5 %), White non-British/Irish (n = 116, 5.7 %), Indian (n = 41,
2.0 %), Pakistani (n = 27, 1.3 %), Chinese (n = 19, 0.9 %), other
Asian/African–Caribbean/African/Arab/Bangladeshi/Other (n =
90, 4.30 %). Regarding participants’ highest level of educational
achievement, 19.0 % (n = 385) had completed O-Level/GCSE or
similar, 18.1 % (n = 366) had completed A-Level or similar, 28.2 %
(n = 572) had completed an undergraduate degree and 15.6 % (n
= 316) had completed a postgraduate degree, with 19.1 % (n =
386) reporting no qualifications, diploma, other qualifications or
technical qualification. Nearly half of the respondents were in
full-time employment (48.8 %, n = 988), 15.0 % (n = 303) were in
part-time employment, 16.5 % (n = 334) were retired, 4.7 % (n =
95) were students, 5.1 % (n = 103) were currently unemployed and
seeking work, 3.4 % (n = 69) were not working owing to disability,
and 6.6 % (n = 133) were unemployed and not seeking work.
Measures
Demographic
Self-reported gender and age were recorded, and age was also cate-
gorised into a six-level variable for the regression analysis.
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Living area
Participants were asked ‘Do you consider yourself to live in:’ and
were required to choose one of the options provided: ‘City’,
‘Suburb’, ‘Town’ or ‘Rural’.
Lone adult: Participants were asked ‘Howmany adults (18 years
or above) live in your household (including yourself)?’ and were
provided with options ranging from ‘1’ to ‘10 or more’. The data
were recoded into a binary variable to represent living alone.
Children
Participants were asked ‘How many children (below the age of 18)
live in your household?’ and were provided with options ranging
from ‘1’ to ‘10 or more’. The scores were categorised into four
groups (0, 1, 2, 3 or more children).
Income
Participants were asked ‘Please choose from the following options to
indicate your approximate gross (before tax is taken away) house-
hold income in 2019 (last year). Include income from partners
and other family members living with you and all kinds of earnings
including salaries and benefits’ and to choose one of five categories:
‘£0–£300 per week (equals about £0–£1290 per month or £0–15 490
per year)’, ‘£301–£490 per week (equals about £1291–£2110 per
month or £15 491–£25 340 per year)’, ‘£491–£740 per week
(equals about £2111–£3230 per month or £25 341–£38 740 per
year)’, ‘£741–£1111 per week (equals about £3231–£4830
per month or £38 741–£57 930 per year)’ and ‘£1112 or more per
week (equals about £4831 or more per month or £57 931 or more
per year)’.
Loss of income
Participants were asked ‘Some people have lost income because of
the coronavirus COVID-19 pandemic, for example because they
have not been able to work as much or because business contracts
have been cancelled or delayed. Please indicate whether your house-
hold has been affected in this way’, and the response options were
‘My household has lost income because of the coronavirus
COVID-19 pandemic’, ‘My household has not lost income
because of the coronavirus COVID-19 pandemic, and ‘I do not
know whether my household has lost income because of the corona-
virus COVID-19 pandemic’. The first option was considered as ‘Yes’
(1) and the other options were collapsed to represent ‘No’.
Health problems
Participants were asked ‘Do you have diabetes, lung disease, or heart
disease?’, and the response options were ‘Yes’ (1) and ‘No’ (0). They
were also asked ‘Do any of your immediate family have diabetes,
lung disease, or heart disease?’, and the response options were
‘Yes’ (1) and ‘No’ (0).
COVID-19 status, self and other
Participants were asked ‘Have you been infected by the coronavirus
COVID-19?’, and six responses were provided. These were col-
lapsed into a binary variable representing ‘Perceived infection
status’. Positive perceived infection status was based on the selection
of either, ‘I have the symptoms of the COVID-19 virus and think I
may have been infected’ or ‘I have been infected by the COVID-19
virus and this has been confirmed by a test’. Negative perceived
infection status was based on the selection of either, ‘No. I have
been tested for COVID-19 and the test was negative’, ‘No, I do
not have any symptoms of COVID-19’, ‘I have a few symptoms of
cold or flu but I do not think I am infected with the COVID-19
virus’ or ‘I may have previously been infected by COVID-19 but
this was not confirmed by a test and I have since recovered’.
Positive status (self) was coded ‘1’ and negative status was coded
as ‘0’.
Participants were also asked ‘Has someone close to you (a family
member or friend) been infected by the coronavirus COVID-19?’,
and four responses were provided. These were collapsed into a
binary variable representing ‘Perceived infection status – someone
close’. Positive perceived infection status was based on the selection
of either, ‘Someone close to me has symptoms, and I suspect that
person has been infected’ or ‘Someone who is close to me has had
a COVID-19 virus infection confirmed by a doctor’. Negative per-
ceived infection status was based on the selection of either, ‘No’
or ‘Someone close to me has symptoms, but I am not sure if that
person is infected’. Positive status (other) was coded ‘1’ and negative
status was coded as ‘0’.
Perceived risk of COVID-19 infection
Participants were asked ‘What do you think is your personal percent-
age risk of being infected with the COVID-19 virus over the following
time periods?’, and three sliders were presented, one for each time
period: (1) ‘In the next month’, (2) ‘In the next three months’, (3)
‘In the next six months’? The slider had ‘0’ and ‘100’ at the left- and
right-hand extremes, respectively, with 10 point increments, and
the labels ‘No Risk’, ‘Moderate Risk’ and ‘Great Risk’ were shown
on the left-hand, middle and right-hand parts of the scale, respect-
ively. These produced continuous scores for each time period,
ranging from 0 to 100, with higher scores reflecting higher levels of
perceived risk of being infected by COVID-19. The scores were
recoded into ‘low’ (0–33), ‘moderate’ (34–67) and ‘high’ (68–100).
Depression
Nine symptoms of depression were measured using the Patient
Health Questionnaire-9 (PHQ-9).13 Participants indicated how
often they had been bothered by each symptom over the past 2
weeks using a four-point Likert scale ranging from 0 (not at all)
to 3 (nearly every day). Possible scores ranged from 0 to 27, with
higher scores indicative of higher levels of depression. To identify
participants likely to meet the criteria for depressive disorder, a
cut-off score of 10 was used. This cut-off produces adequate sensi-
tivity (0.85) and specificity (0.89), corresponds to ‘moderate’ levels
of depression14 and is used to identify a level of depression that may
require psychological intervention.15 The psychometric properties
of the PHQ-9 scores have been widely supported, and the reliability
of the scale among the current sample was excellent (α = 0.92).
Generalised anxiety
Symptoms of generalised anxiety were measured using the
Generalized Anxiety Disorder 7-item Scale (GAD-7).16 Participants
indicated how often they had been bothered by each symptom over
the past 2 weeks on a four-point Likert scale (0 = Not at all, to 3 =
Nearly every day). Possible scores ranged from 0 to 21, with higher
scores indicative of higher levels of anxiety. A cut-off score of 10
was used; this has been shown to result in sensitivity of 89 % and a
specificity of 82 %.16 The GAD-7 has been shown to produce reliable
and valid scores in community studies,17 and the reliability in the
current sample was high (α = 0.94).
Traumatic stress
The International Trauma Questionnaire (ITQ)18 is a self-report
measure of ICD-11 PTSD based on a total of six symptoms across
the three symptom clusters of re-experiencing, avoidance and
sense of threat: each symptom cluster comprises two symptoms.
Participants were asked to complete the ITQ ‘… in relation to
UK population mental health and COVID‐19
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your experience of the COVID-19 pandemic. Please read each item
carefully, then select one of the answers to indicate how much you
have been bothered by that problem in the past month’. The PTSD
symptoms are accompanied by three items measuring functional
impairment caused by these symptoms. All items are answered on
a five-point Likert scale, ranging from 0 (not at all) to 4 (extremely),
with possible scores ranging from 0 to 24. A score of ≥2 (moder-
ately) is considered ‘endorsement’ of that symptom. A PTSD diag-
nosis requires traumatic exposure and at least one symptom to be
endorsed from each PTSD symptom cluster (re-experiencing,
avoidance and sense of threat), and endorsement of at least one indi-
cator of functional impairment. The psychometric properties of the
ITQ scores have been demonstrated in multiple general popula-
tions19,20 and in clinical and high-risk samples.21,22 The reliability
of the PTSD items was high (α = 0.93).
COVID-19-related anxiety
The survey included a question ‘How anxious are you about the cor-
onavirus COVID-19 pandemic?’, and the participants were pro-
vided with a ‘slider’ (electronic visual analogue scale) to indicate
their degree of anxiety with ‘0’ and ‘100’ at the left- and right-
hand extremes, respectively, and 10 point increments. This pro-
duced continuous scores ranging from 0 to 100, with higher
scores reflecting higher levels of COVID-19-related anxiety. The
scores were recoded into quintiles, and the upper quintile was con-
sidered to be indicative of ‘COVID-19 anxiety’.
Similar recruitment strategies and measures have been used by
international collaborators in other countries, including Ireland,10
Italy, Spain, Saudi Arabia and the United Arab Emirates.
Analysis plan
The analyses were conducted in three linked phases. First, the pre-
valences of generalised anxiety, depression and traumatic stress
were estimated using the established cut-off scores. Second, the
bivariate associations between the predictor variables and the
mental health variables were calculated using logistic regression,
and the associations were reported as odds ratios (ORs) with 95 %
confidence intervals. Third, all predictor variables were entered sim-
ultaneously into multivariate binary logistic regression models to
estimate the unique effect of each predictor variable, and the
associations were reported as ORs.
Results
Based on the cut-off scores for the GAD-7 and the PHQ-9, the
prevalence of depression was 22.1 % (95 % CI 20.3–23.9 %) and
that of anxiety was 21.6 % (95 % CI 19.8–23.4 %). There was no
significant difference between prevalence of depression for males
and females (χ2 (1) = 2.34, P = 0.12), but significantly more females
(25.1 %) screened positive for anxiety than males (17.9 %: χ2 (1) =
15.48, P < 0.001). A variable was computed to represent participants
who screened positive for the most common mental health disorders
(anxiety/depression), either anxiety or depression; the prevalence for
this was 27.7 % (95% CI 25.8–29.7 %), and the prevalence was higher
for females (31.7 %) than for males (23.4 %: (χ2 (1) = 17.57, P <
0.001). Using the diagnostic algorithm for the ITQ, the prevalence
of traumatic stress was 16.79 % (95 % CI 15.2–18.4 %). There was a
significant gender difference, with a higher prevalence of traumatic
stress for males (18.9 %) compared with females (14.9 %: χ2 (1) =
5.85, P < 0.01). The COVID-19 anxiety prevalence was 21.3 % (95
% CI 19.5–23.1 %), and there was a significant gender difference,
with a higher prevalence of COVID-19 anxiety for females (24.6 %)
compared with males (17.7 %: χ2 (1) = 5.85, P < 0.01).
Three binary logistic regression models were used to predict
caseness on COVID-19-related anxiety, anxiety/depression and
traumatic stress. The predictor variables were age, gender, living
location, lone adult status, number of children, income, loss of
income, pre-existing health condition (self and other), COVID-19
infection status (self and other) and personal risk of infection over
the following month.
Table 1 shows the findings for COVID-19-related anxiety,
stratified by the predictor variables, with bivariate associations
(unadjusted) presented as ORs, and ORs from the multivariate
(adjusted) model with all predictors entered. The multivariate
model was significant (χ2 (24) = 139.97, P < 0.001). When the
unadjusted ORs were calculated, only female gender, the presence
of children in the household and estimates of personal risks of infec-
tion were predictive of COVID-related anxiety. However, when the
adjusted effects were calculated, the effect for the presence of chil-
dren became stronger; there was an effect for history of infection,
which should be interpreted with caution in the light of the small
numbers involved; and there was a very strong effect for age, with
older participants reporting more anxiety about the virus.
The multivariate regression models for both anxiety/depression
(χ2 (24) = 292.03, P < 0.001), and traumatic stress (χ2 (24) = 328.58,
P < 0.001) were statistically significant; the unadjusted and adjusted
ORs are shown in Tables 2 and 3. For anxiety/depression, there was
a strong effect for age, contrary to the effect observed for COVID-
related anxiety, with very high levels of psychological symptoms
in the youngest participants and low levels in those over 65 years
of age. A bivariate effect for urban location did not survive in the
multivariate model, and the effect of having children in the house
was much muted in the multivariate model. Participants who had
lost income in the pandemic and those in the lower-income categor-
ies showed markedly higher risk for anxiety/depression. Higher
levels of anxiety/depression were also reported by those who had
pre-existing health conditions, knew someone who had a pre-exist-
ing health condition, had become infected themselves, and/or gave a
high estimate of their personal risk of infection.
Finally, in the case of traumatic stress, there was again a higher
prevalence in younger participants, but the gender effect was
reversed compared with anxiety/depression, with more symptoms
being reported by males. The influence of the presence of children
was marked for both the bivariate associations and the multivariate
model, but there was little effect for income or loss of income when
other variables were controlled for. The lack of an association for
being infected by COVID-19 in the multivariate model should be
interpreted with caution, given the small numbers involved and
the wide confidence intervals. Trauma symptoms were also asso-
ciated with the perception of a high risk of infection.
Discussion
This study was one of the first to measure psychological disorders in
a representative sample of the UK population during a pandemic.
The study had the additional virtues of recruiting participants
early in the crisis and using standardised measures, allowing
follow-up at later stages. We found higher levels of anxiety, depres-
sion and traumatic stress than those previously reported by general
population-based studies. Although previous studies have investi-
gated the psychological effects of past pandemics, particularly the
SARS and H1N1 pandemics in the far east, they mostly considered
the effects on pandemic survivors and health professionals, and the
only population-based studies did not use standardised instru-
ments. For example, a study in Taiwan following the 2003 SARS
pandemic used a five-item symptom-rating scale, and found that
poorer mental health was related to personal experience of SARS
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or knowing people who had been affected.11 In a Chinese study that
employed a short questionnaire during the same pandemic, respon-
dents reported increased fear, anxiety and panic.2However, a longi-
tudinal study of citizens of Hong Kong during the 2009 H1N1
pandemic found low levels of anxiety throughout, but anxiety
levels were associated with compliance with social distancing
advice.1
Our primary aim was to assess the levels of anxiety, depression
and traumatic stress in the population during the early stages of the
COVID-19 pandemic. The prevalence of anxiety (21.63 %) and
depression (22.12 %) found in this study appear to be higher than
those previously reported, but not markedly so. The English 2014
Adult Psychiatric Morbidity Survey (APMS)23 reported that 15.7 %
of the sample experienced symptoms of commonmental health dis-
orders, based on a cut-off score of 12 on the Clinical Interview
Schedule-Revised, with a higher prevalence for women (19.1 %)
than for men (12.2 %). The prevalence of anxiety or depression in
the Understanding Society study in 2014 was 19.7 % (22.5 % for
females, 16.8 % for males),24 based on the General Health
Questionnaire (GHQ). The closest comparable study is probably
the National Institute for Health Research Applied Research
Collaboration North West Coast Household Health Survey, which
administered the PHQ9 and GAD7 (face-to-face) to 4000 people
in the north-west of England, mainly living in deprived areas; in
this study, 17 % were depressed and 13 % were anxious.25A recently
published study used data from the Understanding Society COVID-
19 web survey, and reported the population prevalence of clinically
significant levels of mental distress to be 27.3 %.26 The study used
the GHQ to identify clinically significant distress, and data collec-
tion was approximately 1 month after our data collection period,
but despite these differences the GHQ prevalence was similar to
that based on meeting the criteria for either anxiety or depression
Table 1 Bivariate and multivariate binary logistic regression results predicting COVID-related anxiety
COVID-19 anxiety
Unadjusted OR Adjusted ORN N (%)
Age
18–24 246 42 (17.1 %) – –
25–34 380 66 (17.4 %) 1.02 (0.667–1.56) 0.93 (0.59–1.46)
35–44 353 75 (21.2 %) 1.31 (0.86–1.99) 1.40 (0.88–2.21)
45–54 410 96 (23.4 %) 1.48 (0.99–2.22) 1.99 (1.28–3.07)**
55–64 349 84 (24.1 %) 1.54 (1.02–2.33)* 2.58 (1.63–4.08)***
65+ 287 68 (23.7 %) 1.51 (0.98–2.32) 2.42 (1.50–3.91)***
Gender
Female 1047 258 (24.6 %) – –
Male 972 172 (17.7 %) 0.65 (0.53–0.82)*** 0.586 (0.463–0.743)***
Living location
Rural 335 74 (22.1 %) – –
Town 620 130 (21.0 %) 0.94 (0.68–1.29) 0.92 (0.65–1.29)
Suburb 572 106 (18.5 %) 0.80 (0.57–1.12) 0.77 (0.54–1.09)
City 498 121 (24.3 %) 1.13 (0.81–1.57) 1.20 (0.84–1.71)
Lone adult
No 1571 337 (21.5 %) – –
Yes 454 94 (20.7 %) 0.96 (0.740–1.24) 0.971 (0.716–1.317)
Children
0 1429 283 (19.7 %) – –
1 292 56 (19.1 %) 0.96 (0.70–1.32) 1.09 (0.77–1.55)
2 237 73 (30.7 %) 1.80 (1.33–2.44)*** 2.11 (1.49–2.98)***
3+ 61 19 (31.1 %) 1.84 (1.05–3.21)* 2.35 (1.29–4.28)**
Income
£57 930+ 410 77 (18.8 %) – –
−£57 930 pa 410 86 (21.0 %) 1.15 (0.81–1.62) 1.15 (0.80–1.65)
−£38 740 pa 385 88 (22.9 %) 1.28 (0.91–1.81) 1.40 (0.97–2.03)
−£25 340 pa 410 86 (21.0 %) 1.15 (0.82–1.62) 1.37 (0.94–2.02)
£0–15 490 pa 410 94 (22.9 %) 1.29 (0.92–1.80) 1.30 (0.881–1.92)
Lost income
Not lost 1377 282 (20.5 %) – –
Lost 648 149 (23.0 %) 1.16 (0.93–1.45) 1.18 (0.93–1.51)
Pre-existing health condition, self
No 1714 348 (20.3 %) – –
Yes 311 83 (26.7 %) 1.43 (1.08–1.89)* 1.24 (0.91–1.69)
Pre-existing health condition, someone close
No 1510 305 (20.2 %) – –
Yes 515 126 (24.5 %) 1.28 (1.01–1.62)* 1.07 (0.82–1.39)
COVID-19, self
No 1977 425 (21.5 %) –
Yes 48 6 (12.5 %) 0.52 (0.22–1.23) 0.39 (0.16–.99)*
COVID-19, someone close
No 1913 407 (21.3 %) – –
Yes 112 24 (21.4 %) 1.01 (0.63–1.61) 0.89 (0.54–1.45)
Personal risk 1 month
Low 633 81 (12.8 %) –
Moderate 867 182 (21.0 %) 1.81 (1.36–2.41)*** 1.75 (1.31–2.34)***
High 525 168 (32.0 %) 3.21 (2.38–4.31)*** 3.14 (2.31–4.28)***
* P < 0.05, **P < 0.01, ***P < 0.001.
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in this study, which was 27.7 %. This may be indicative of a stable
psychological response during the first month of lockdown,
although longitudinal studies will be required to determine the lon-
gitudinal change during lockdown.
The prevalence of PTSD in this current study was 16.79 %,
similar to the combined prevalence of PTSD and complex PTSD
in a UK trauma-exposed sample (prevalence of 5.3 % for PTSD
and 12.9 % for complex PTSD27), and much higher than that
reported by the APMS (4.4 %, with no gender differences
found11). However, these comparisons should be treated with
caution, as the status of COVID-19 as a traumatic stressor is not
clear. Unexpectedly, the prevalence for males was higher than that
for females; most epidemiological studies report a higher prevalence
of PTSD for females.28 The reasons for this are not immediately
clear, but the health and economic threats that COVID-19 poses
may be undermining traditional male gender roles, or the higher
prevalence of mortality for males during the British COVID-19 pan-
demic may play a part.
The unadjusted estimates for the model predicting anxiety/
depression revealed that younger age, being female, living in a
city, pre-existing health conditions, COVID-19 status and perceived
risk of COVID-19 infection all significantly increased the likelihood
of screening positive for anxiety or depression.
Contrary to expectations, the oldest age group and being male
were associated with a lower likelihood of anxiety or depression,
despite these factors being associated with higher COVID-19-
related mortality.29 In the 2014 Adult Psychiatric Morbidity
Survey, a much lower prevalence of common psychological disor-
ders was observed in those over 65 compared with those of
working age, although the effect was nonlinear and the high preva-
lence observed for those under 35 in this study were not evident
there. Strikingly, the opposite relationship with age was observed
Table 2 Bivariate and multivariate binary logistic regression results predicting anxiety/depression
Anxiety/depression
Unadjusted OR Adjusted ORN N (%)
Age
18–24 246 121 (49.2 %) – –
25–34 380 152 (40.0 %) 0.69 (0.50–0.95)* 0.67 (0.47–0.95)*
35–44 353 97 (27.5 %) 0.39 (0.278–0.551)*** 0.408 (0.28–0.60)***
45–54 410 96 (23.4 %) 0.32 (0.22–0.44) *** 0.36 (0.25–0.52)***
55–64 349 68 (19.5 %) 0.25 (0.17–0.36) *** 0.31 (0.21–0.47)***
65+ 287 28 (9.8 %) 0.11 (0.07–0.18) *** 0.141 (0.09–0.23)***
Gender
Female 1047 227 (23.4 %) – –
Male 972 332 (31.70 %) 0.65 (0.54-0.80)*** 0.89 (0.71–1.12)
Living location
Rural 335 77 (23.0 %) – –
Town 620 167 (26.9 %) 1.23 (0.91–1.68) 1.02 (0.73–1.43)
Suburb 572 138 (24.1 %) 1.06 (0.77–1.46) 0.98 (0.70–1.39)
City 498 180 (36.1 %) 1.90 (1.39–2.59)*** 1.21 (0.86–1.7)
Lone adult
No 1571 424 (27.0 %) – –
Yes 454 138 (30.4 %) 1.18 (0.94–1.48) 1.32 (0.99–1.75)
Children
0 1429 355 (24.8 %) – –
1 292 95 (32.4 %) 1.46 (1.11–1.91)** 1.19 (0.88–1.61)
2 237 90 (37.8 %) 1.84 (1.38–2.46)*** 1.41 (1.01–1.96)*
3+ 61 22 (36.1 %) 1.71 (1.00–2.93)* 1.41 (0.79–2.53)
Income
£57 930+ 410 70 (17.1 %) – –
−£57 930 pa 410 91 (22.2 %) 1.39 (0.98–1.96) 1.28 (0.89–1.85)
−£38 740 pa 385 117 (30.4 %) 2.12 (1.51–2.97)*** 1.69 (1.17–2.44)**
−£25 340 pa 410 135 (32.9 %) 2.38 (1.71–3.31)*** 1.67 (1.15–2.42)**
£0–15 490 pa 410 149 (36.3 %) 2.77 (2.00–3.84)*** 2.44 (1.67–3.56)***
Lost income
Not lost 1377 323 (23.5 %) – –
Lost 648 239 (36.9 %) 1.91 (1.56–2.33)*** 1.25 (1.25–1.95)***
Pre-existing health condition, self
No 1714 452 (26.4 %) – –
Yes 311 110 (35.4 %) 1.53 (1.18–1.97)** 1.45 (1.07–1.96)*
Pre-existing health condition, someone close
No 1510 386 (25.6 %) – –
Yes 515 176 (34.2 %) 1.51 (1.22–1.88)*** 1.33 (1.03–1.74)*
COVID-19, self
No 1977 535 (27.1 %) –
Yes 48 27 (56.3 %) 3.46 (1.94–6.18)*** 2.17 (1.14–4.11)**
COVID-19, someone close
No 1913 515 (26.9 %) – –
Yes 112 47 (42.0 %) 1.96 (1.33–2.89)** 1.50 (0.97–2.32)
Personal risk, 1 month
Low 633 139 (22.0 %) – –
Moderate 867 208 (24.0 %) 1.12 (0.88–1.43) 1.13 (0.87–1.47)
High 525 215 (41.0 %) 2.46 (1.91–3.18)*** 2.20 (1.66–2.91)***
* P < 0.05, ** P < 0.01, ***P < 0.001.
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for anxiety specifically about the COVID-19 pandemic, which was
related to mortality risk in a logical way. The adjusted estimates
were generally attenuated, but the same pattern of associations
was found. The unadjusted estimates for the model predicting trau-
matic stress differed in that being male was a significant risk factor,
and there was a large effect for living in an urban area.
This study had both strengths and limitations. On the strengths
side, the sample was highly representative of the UK population, was
recruited early in the progress of the pandemic, and used standar-
dised measures, allowing comparisons with findings from later
stages of the COVID-19 crisis. However, despite the sampling
frame and large sample size, and although the participants in this
study were representative of the UK population in terms of demo-
graphic, economic and social factors, as well as voting history, it
was not a true random probability sample (which would have
been very difficult to obtain under the current circumstances),
and it is possible that individuals’ decisions about whether to par-
ticipate were affected by psychological factors, creating the possibil-
ity of sampling bias. Second, all mental health assessments were
based on self-report and not clinician-administered interviews;
this may have resulted in overestimation of prevalence. Third, the
validity of the assessment of traumatic stress may be questioned,
as it is not clear whether the COVID-19 pandemic meets the
ICD-11 criteria (‘an extremely threatening or horrific event or
series of events’) or DSM-5 criteria (direct exposure, witnessing
the trauma, learning that a relative or close friend was exposed to
a trauma, indirect exposure to aversive details of the trauma,
usually in the course of professional duties) for a traumatic event
for the entire population. This question is already being
debated,30 with arguments being made that the global nature of
the threat, its wide ranging effects (i.e. health, economic and
social), and the widespread reports of behaviours and cognitions
Table 3 Bivariate and multivariate binary logistic regression results predicting traumatic stress
Traumatic stress
Unadjusted OR Adjusted ORN N (%)
Age
18–24 246 59 (24.0 %) – –
25–34 380 109 (28.7 %) 1.27 (0.88–1.84) 0.99 (0.65–1.49)
35–44 353 88 (24.9 %) 1.05 (0.72–1.54) 0.74 (0.48–1.15)
45–54 410 53 (12.9 %) 0.47 (0.31–0.71)*** 0.39 (0.25–0.62)***
55–64 349 24 (6.9 %) 0.23 (0.14–0.39)*** 0.31 (0.18–0.54)***
65+ 287 7 (2.4 %) 0.08 (0.03–0.18)*** 0.09 (0.04–0.22)***
Gender
Female 1047 156 (14.9 %) – –
Male 972 184 (18.9 %) 1.33 (1.06–1.68)* 1.85 (1.41–2.44) ***
Living location
Rural 335 36 (10.7 %) – –
Town 620 76 (12.3 %) 1.16 (0.76–1.77) 0.94 (0.60–1.50)
Suburb 572 88 (15.4 %) 1.51 (0.99–2.28) 1.24 (0.79–1.94)
City 498 140 (28.1 %) 3.25 (2.18–4.83)*** 1.91 (1.23–2.94)**
Lone adult
No 1571 268 (17.1 %) – –
Yes 454 72 (15.9 %) 0.92 (0.69–1.22) 1.412 (0.99–2.00)
Children
0 1429 163 (11.4 %) – –
1 292 75 (25.6 %) 2.68 (1.96–3.65)*** 1.83 (1.30–2.58)**
2 237 83 (34.9 %) 4.17 (3.05–5.70)*** 2.56 (1.78–3.68)***
3+ 61 19 (31.1 %) 3.52 (2.00–6.21)*** 2.39 (1.29–4.44)**
Income
£57 930+ 410 49 (12.0 %) – –
−£57 930 pa 410 59 (14.4 %) 1.24–(0.82–1.86) 1.27 (0.82–1.98)
−£38 740 pa 385 81 (21.0 %) 1.96 (1.33–2.88)** 1.55 (0.99–2.40)
−£25 340 pa 410 98 (23.9 %) 2.31 (1.59–3.36)*** 1.85 (1.19–2.87)**
£0–15 490 pa 410 53 (12.9 %) 1.09 (0.72–1.65) 1.28 (0.78–2.07)
Lost income
Not lost 1377 196 (14.2 %) – –
Lost 648 144 (22.2 %) 1.722 (1.36–2.18)*** 1.27 (0.97–1.66)
Pre-existing health condition, self
No 1714 279 (16.3 %) – –
Yes 311 61 (19.6 %) 1.25 (0.92–1.71) 1.21 (0.829–1.77)
Pre-existing health condition, someone close
No 1510 247 (16.4 %) – –
Yes 515 93 (18.1 %) 1.13 (0.87–1.46) 1.13 (0.82–1.56)
COVID-19, self
No 1977 324 (16.4 %) – –
Yes 48 16 (33.3 %) 2.55 (1.38–4.70)** 1.03 (0.50–2.12)
COVID-19, someone close
No 1913 305 (15.9 %) – –
Yes 112 35 (31.3 %) 2.39 (1.57–3.64)*** 1.70 (1.04–2.77)*
Personal risk, 1 month
Low 633 54 (8.5 %) – –
Moderate 867 132 (15.2 %) 1.92 (1.37–2.69)*** 1.88 (1.32–2.68)**
High 525 154 (29.3 %) 4.45 (3.18–6.23)*** 3.55 (2.47–5.09)***
* P < 0.05, **P < 0.01, ***P < 0.001.
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analogous to PTSD symptoms (heightened perceptions of threat,
voluntary (and enforced) avoidance, and re-experiencing being
facilitated by mainstream and social media) mean that the pan-
demic should be considered a traumatic stressor. Finally, the
mechanisms by which the threat of the pandemic and/or the quar-
antine influenced mental health could not be established. Previous
research has identified disruptions in circadian rhythms,31 disrup-
tions in social contact32 and quarantine related stressors as import-
ant contributing factors.33
Conclusions
Modelling studies have suggested that the influence of pandemics
on psychological disorders in the general population may affect
the progress of a pandemic and, therefore, indirectly affect mortal-
ity.6 Furthermore, the development of psychological disorders in the
population may create a burden that impedes national social and
economic recovery once the pandemic ends. The fact that the preva-
lence of psychological problems observed in the present study was
not dramatically higher than those reported in previous studies sug-
gests that the population, at an early stage of the pandemic, has suc-
cessfully adapted to the unprecedented changes that have been
forced on their lifestyles. However, we have identified certain key
groups who may be more vulnerable to the social and economic
challenges of the pandemic, particularly those whose income has
been affected, who have children living in the home and who
have pre-existing health conditions that make them vulnerable to
the more devastating effects of the COVID-19 virus. Further
research is needed to track whether these groups show higher
levels of psychological problems at later stages in the pandemic
and whether specific interventions and policies should be developed
to address their needs.
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